CureVac COVID-19 vaccine hits just 48% efficacy in final analysis
https://healthell.blogspot.com/2021/07/curevac-covid-19-vaccine-hits-just-48.html
CureVac COVID-19 vaccine hits just 48% efficacy in final analysis
German biotech company CureVac announced its COVID-19 vaccine demonstrated 48% efficacy against COVID-19 of any severity in a final readout of late-stage trial data.
